Fluid component analysis system and method for glucose monitoring and control
US7972296B2 · kind B2 · utility
306Cited by
85References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2008 |
| Grant date | Jul 5, 2011 |
| Priority date | — |
| Expiry date | Oct 10, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2230/201
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g. insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.